JKIL achieved strong performance during 3QFY20. FY20/21E Rev guidance is maintained at Rs 32/36bn. Order book is robust at 2.55x FY20E Revenue. With strong execution visibility on current order book, JKIL is well placed for re-rating. At CMP JKIL trades at 4.8x FY21E EPS. We maintain BUY. Key risks (1) Geographic concentration (2) Order conversion within estimated timelines. JKIL delivered 1/(10)/(4)% 3QFY20 Rev/EBIDTA/APAT beat/(miss). We retain our FY20/21E Revenue estimates while revising FY20/21E APAT estimates by 0.4/(2.6)%. We maintain BUY on JKIL with a TP of Rs 269/sh (vs. Rs 276/sh earlier, 8x Mar-21E EPS).